Your browser doesn't support javascript.
loading
Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.
Grace, Rachael F; Shimano, Kristin A; Bhat, Rukhmi; Neunert, Cindy; Bussel, James B; Klaassen, Robert J; Lambert, Michele P; Rothman, Jennifer A; Breakey, Vicky R; Hege, Kerry; Bennett, Carolyn M; Rose, Melissa J; Haley, Kristina M; Buchanan, George R; Geddis, Amy; Lorenzana, Adonis; Jeng, Michael; Pastore, Yves D; Crary, Shelley E; Neier, Michelle; Neufeld, Ellis J; Neu, Nolan; Forbes, Peter W; Despotovic, Jenny M.
Afiliação
  • Grace RF; Division of Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Boston, Massachusetts.
  • Shimano KA; Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, UCSF Benioff Children's Hospital, San Francisco, California.
  • Bhat R; Center for Cancer & Blood Disorders, Ann and Robert H. Lurie Childrens Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Neunert C; Division of Hematology, Oncology, and Stem Cell Transplant, Columbia University Medical School, New York, New York.
  • Bussel JB; Department of Pediatrics, Weill Cornell Medicine, New York, New York.
  • Klaassen RJ; Division of Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
  • Lambert MP; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Rothman JA; Division of Pediatric Hematology/Oncology, Duke University Medical Center, Durham, North Carolina.
  • Breakey VR; Division of Pediatric Hematology/Oncology, McMaster University, Hamilton, Ontario, Canada.
  • Hege K; Division of Pediatric Hematology/Oncology, Riley Hospital at IU Health, Indiana University School of Medicine, Indianapolis, Indiana.
  • Bennett CM; Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia.
  • Rose MJ; Division of Hematology, Oncology, and Bone Marrow Transplant, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio.
  • Haley KM; Division of Pediatric Hematology, Oregon Health & Science University, Portland, Oregon.
  • Buchanan GR; Division of Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Geddis A; Division of Pediatric Hematology/Oncology, University of Washington, Seattle Children's Hospital, Seattle, Washington.
  • Lorenzana A; Division of Pediatric Hematology/Oncology, St. John Ascension Hospital, Detroit, Michigan.
  • Jeng M; Department of Pediatrics, Stanford School of Medicine, Palo Alto, California.
  • Pastore YD; Division of Hematology/Oncology, CHU Sainte-Justine, Montreal, Québec, Canada.
  • Crary SE; Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
  • Neier M; Division of Pediatric Hematology/Oncology, Goryeb Children's Hospital, Morristown, New Jersey.
  • Neufeld EJ; Division of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Neu N; Division of Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Boston, Massachusetts.
  • Forbes PW; Clinical Research Center, Boston Children's Hospital, Boston, Massachusetts.
  • Despotovic JM; Department of Pediatrics, Hematology/Oncology Section, Baylor College of Medicine, Houston, Texas.
Am J Hematol ; 94(7): 741-750, 2019 07.
Article em En | MEDLINE | ID: mdl-30945320

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Trombopoetina / Proteínas Recombinantes de Fusão / Receptores Fc / Púrpura Trombocitopênica Idiopática / Rituximab Tipo de estudo: Clinical_trials / Observational_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Trombopoetina / Proteínas Recombinantes de Fusão / Receptores Fc / Púrpura Trombocitopênica Idiopática / Rituximab Tipo de estudo: Clinical_trials / Observational_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article